Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 5495

1.

KRAS mutations drive adenomatoid odontogenic tumor and are independent of clinicopathological features.

Coura BP, Bernardes VF, de Sousa SF, França JA, Pereira NB, Pontes HAR, Batista AC, da Cruz Perez DE, Albuquerque Junior RLC, de Souza LB, Martins MD, Diniz MG, Gomez RS, Gomes CC.

Mod Pathol. 2019 Jan 14. doi: 10.1038/s41379-018-0194-4. [Epub ahead of print]

PMID:
30643167
2.

Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma.

Shanmugam V, Griffin GK, Jacobsen ED, Fletcher CDM, Sholl LM, Hornick JL.

Mod Pathol. 2019 Jan 9. doi: 10.1038/s41379-018-0200-x. [Epub ahead of print]

PMID:
30626916
3.

NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma.

Pei J, Cooper H, Flieder DB, Talarchek JN, Al-Saleem T, Uzzo RG, Dulaimi E, Patchefsky AS, Testa JR, Wei S.

Mod Pathol. 2019 Jan 8. doi: 10.1038/s41379-018-0191-7. [Epub ahead of print]

PMID:
30622287
4.

Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile.

Sarungbam J, Mehra R, Tomlins SA, Smith SC, Jayakumaran G, Ahmadie HA, Gopalan A, Sirintrapun SJ, Fine SW, Zhang Y, Amin MB, Reuter VE, Chen YB, Tickoo SK.

Mod Pathol. 2019 Jan 8. doi: 10.1038/s41379-018-0185-5. [Epub ahead of print]

PMID:
30622286
5.

The utilization of cytologic and small biopsy samples for ancillary molecular testing.

Roh MH.

Mod Pathol. 2019 Jan 2. doi: 10.1038/s41379-018-0138-z. [Epub ahead of print] Review.

PMID:
30600323
6.

A practical guide to biomarkers for the evaluation of colorectal cancer.

Chen W, Frankel WL.

Mod Pathol. 2019 Jan 2. doi: 10.1038/s41379-018-0136-1. [Epub ahead of print] Review.

PMID:
30600322
7.

The diagnosis of non-small cell lung cancer in the molecular era.

Brainard J, Farver C.

Mod Pathol. 2019 Jan 2. doi: 10.1038/s41379-018-0156-x. [Epub ahead of print] Review.

PMID:
30600321
8.

Limited biopsies of soft tissue tumors: the contemporary role of immunohistochemistry and molecular diagnostics.

Hornick JL.

Mod Pathol. 2019 Jan 2. doi: 10.1038/s41379-018-0139-y. [Epub ahead of print] Review.

PMID:
30600320
9.

Pearls and pitfalls in the diagnostic workup of small lymph node biopsies.

Ranheim EA.

Mod Pathol. 2019 Jan 2. doi: 10.1038/s41379-018-0151-2. [Epub ahead of print] Review.

PMID:
30600319
10.

Problematic issues in breast core needle biopsies.

Schnitt SJ.

Mod Pathol. 2019 Jan 2. doi: 10.1038/s41379-018-0137-0. [Epub ahead of print] Review.

PMID:
30600318
11.

Fine needle aspiration and core needle biopsy of metastatic malignancy of unknown primary site.

Elsheikh TM, Silverman JF.

Mod Pathol. 2019 Jan 2. doi: 10.1038/s41379-018-0149-9. [Epub ahead of print] Review.

PMID:
30600317
12.

A little piece of mind: best practices for brain tumor intraoperative consultation.

Fuller C.

Mod Pathol. 2019 Jan 2. doi: 10.1038/s41379-018-0147-y. [Epub ahead of print] Review.

PMID:
30600316
13.

ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion.

Chang KTE, Tay AZE, Kuick CH, Chen H, Algar E, Taubenheim N, Campbell J, Mechinaud F, Campbell M, Super L, Chantranuwat C, Yuen ST, Chan JKC, Chow CW.

Mod Pathol. 2018 Dec 20. doi: 10.1038/s41379-018-0168-6. [Epub ahead of print]

PMID:
30573850
14.

MUC4 Staining in Sarcomatoid Carcinomas.

Berg KB, Ionescu D, Churg AM.

Mod Pathol. 2019 Jan;32(1):157. doi: 10.1038/s41379-018-0022-x. Epub 2018 Dec 19. No abstract available.

PMID:
30568230
15.

Reply to 'MUC4 staining in sarcomatoid carcinomas' by Berg et al.

Amatya VJ, Kushitani K, Mawas AS, Miyata Y, Okada M, Kishimoto T, Inai K, Takeshima Y.

Mod Pathol. 2019 Jan;32(1):158. doi: 10.1038/s41379-018-0119-2. Epub 2018 Dec 19. No abstract available.

PMID:
30568229
16.

Interobserver variability in colorectal cancer and the 2016 ITBCC concensus.

Lino-Silva LS, Gamboa-Domínguez A, Zúñiga-Tamayo D, López-Correa P.

Mod Pathol. 2019 Jan;32(1):159-160. doi: 10.1038/s41379-018-0027-5. Epub 2018 Dec 19. No abstract available.

PMID:
30568228
17.

Reply to: Interobserver variability in colorectal cancer and the 2016 ITBCC consensus.

Dawson H, Kirsch R, Lugli A; participants of the International Tumor Budding Consensus Conference 2016 (1).

Mod Pathol. 2019 Jan;32(1):161-162. doi: 10.1038/s41379-018-0104-9. Epub 2018 Dec 19. No abstract available.

PMID:
30568227
18.

Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic method.

Takamatsu M, Kawachi H, Yamamoto N, Kobayashi M, Toyama Y, Maekawa T, Chino A, Saito S, Ueno M, Takazawa Y, Ishikawa Y.

Mod Pathol. 2018 Dec 14. doi: 10.1038/s41379-018-0189-1. [Epub ahead of print]

PMID:
30552417
19.

Bevacizumab-associated glomerular microangiopathy.

Person F, Rinschen MM, Brix SR, Wulf S, Noriega MLM, Fehrle W, Schmitz J, Schwarz A, Ivanyi P, Steinmetz OM, Reinhard L, Hoxha E, Zipfel PF, Bräsen JH, Wiech T.

Mod Pathol. 2018 Dec 14. doi: 10.1038/s41379-018-0186-4. [Epub ahead of print]

PMID:
30552416
20.

Human papillomavirus in laryngeal and hypopharyngeal lymphoepithelial carcinoma.

Acuña G, Gomà M, Temprana-Salvador J, Garcia-Bragado F, Alós L, Ordi J, Cardesa A, Nadal A.

Mod Pathol. 2018 Dec 14. doi: 10.1038/s41379-018-0188-2. [Epub ahead of print]

PMID:
30552415

Supplemental Content

Loading ...
Support Center